49 results about "Rubus sachalinensis" patented technology

Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to express novel recombinant genes encoding steviol biosynthetic enzymes and UDP-glycosyltransferases (UGTs). Such microorganisms, plants, or plant cells can produce steviol or steviol glycosides, e.g., rubusoside or Rebaudioside A, which can be used as natural sweeteners in food products and dietary supplements.

The invention discloses a medicament for treating flu, which comprises the following raw materials in parts by weight: 1 to 100 parts of Tibet inula root paste, 1 to 80 parts of Tibet inula root, 25 to 250 parts of rubus flosculosus (peel the skins, extract the buds), 10 to 175 parts of caulis tinosporae (peel the skins), 1 to 75 parts of rhizoma zingiberis, 8 to 125 parts of Fructus Chebulae (denucleated), 5 to 160 parts of phyllanthus emblica, 1 to 75 parts of Fructus Terminaliae Billericae (denucleated) and 1 to 200 parts of Phlomis younghusbandii, and the grain diameter of the medicament is 0.1-100 mum. The medicament has the advantages of higher effective medicine dissolution rate, medicine infiltration capacity and bioavailability and good effect. The invention further discloses a preparation method of the medicament for treating flue and a special quality detecting method thereof. The quality detecting method is used for effectively distinguishing the specificities of the raw materials in the medicine while controlling the stability of the medicine.

A composition is provided for use in health foods for promoting the circulation of blood, prepared from medicinal herbs, including Lycium chinense Miller, Agastache rugosa (Fischer et Meyer) O. Kuntze, Pueraria lobat Ohwi, Macrocarpium officinale Sieb. et Zucc., Gastrodia elata blume, Amomum xanthioides Wallich, Cratagegus pinnatifida Bge., Aquillaria Agallocha Roxburgh, Inula Helenium L., Cassia obtusifolia L., and Rubus sachalinensis Lev., and young antlers of Cornu cervi. In addition to being safe to the body, the composition exhibits excellent pharmaceutical effects of treating arteriosclerosis and alleviating the headache attributed to the disturbance of blood circulation.

There are proposed substance mixtures comprising

• (a) 20 to 80% by weight of monocyclic terpenes and
• (b) 80 to 20% by weight of active substances selected from the group consisting of rebaudiosides or plant extracts comprising them, steviosides or plant extracts comprising them, naringin dihydrochalcone, mogrosides or plant extracts comprising them, rubusosides or plant extracts comprising them.

The invention relates to a traditional Chinese medicine for the treatment of galactostasis and mastitis complications, which is prepared from the following herbal raw materials: diversileaf artocarpus seeds, rhizome of omei mountain bamboo, stem of false tomentoseanther clematis, sunset abelmoschus seeds, echinops gmelinii turcz., Tibetan clematis stem, rubus alceaefolius poir, peking spleenwort, herb of stemless launaea, oxalis purpurea white, and fructus forsythiae. Clinical experiments show that the traditional Chinese medicine can safely and effectively treat galactostasis and mastitis.

The invention relates to a traditional Chinese medicine for treating pseudomembranous enteritis, which is prepared from the following medicinal materials in parts by weight: 30 parts of Bidens alba, 15 parts of Senecio asperifolius, 15 parts of Cheilotheca humilis, 12 parts of Crotalaria calycina, 6 parts of Biophytum esquirolii levl., 30 parts of buttonbush root, 10 parts of Japanese Premna Herb, 15 parts of Sanicula orthacantha, 20 parts of Oenothera rosea, 60 parts of dentes foxtail, 20 parts of sakhalin raspberry root and 10 parts of Pellionia radicans. The clinical experiment proves that the traditional Chinese medicine can safely and effectively treat pseudomembranous enteritis.

The present disclosure provides a use of Rubus fruticosus extract for manufacturing a skincare composition, where the composition is used for reducing oxidative damage caused by reactive oxygen species in cells, reducing the amount of hemoglobin in skin, inhibiting melanin production, reducing skin redness spots, and enhance the skin's moisturizing ability.

The invention provides a traditional Chinese medicine composite for treating livestock plague. The composite comprises a first component and a second component. The first component comprises the following components in parts by weight: 25 parts of radix glehniae, 5 parts of liquorice, 7.5 parts of rhizoma bistortae, 14 parts of laccifer lacca, 50 parts of inula helenium, 25 parts of ramulus rubi,50 parts of radix sophorae flavescentis, 12.5 parts of rhizoma kaempferiae, 25 parts of fructus chebulae, 15 parts of szechwan chinaberry fruit and 30 parts of fructus gardenia; and the second component comprises the following components in parts by weight: 60 parts of folium isatidis, 60 parts of radix isatidis, 60 parts of gypsum, 30 parts of radix et rhizoma rhei and 30 parts of weathered sodium sulfate. The medicine provided can effectively treat livestock plague. Result of the embodiment shows that: the treatment validity rate of the medicine prepared in livestock plague is 90%.

The invention discloses rubus sachalinensis root-flavored pickled Chinese cabbage shreds capable of dispelling wind and clearing away heat and a making method thereof. The pickled Chinese cabbage shreds are made from, by weight, 1,000-1,200 parts of Chinese cabbages, 13-15 parts of rubus sachalinensis roots, 8-10 parts of herb of lophanthus krylovii Lipsky, 8-10 parts of villose ardisia roots or herb, 4-6 parts of rhizomes of ophiopogon dracaenoides (Baker) Hook.f., 4-6 parts of herb of triaenophora rupestris (Hemsl.) solereder, 4-6 parts of herb of gymnotheca involucrate, 1-3 parts of roots of fissistigma glaucescens (Hance) Merr., 1-3 parts of fruits of elaeagnus viridis Servett. var. delavayi Lecte., 1-3 parts of herb of panzeria alashanica Kupr., 1-3 parts of herb of zinnia elegans Jacq., 15-20 parts of pickling seasonings, 10-15 parts of lean meat granules, 10-15 parts of seasoning powder, 5-10 parts of seasoning oil, 5-10 parts of nutrition powder and 5-10 parts of sour liquid. The pickled Chinese cabbage shreds are advanced in process, scientific in adopted material, easy to process and make and suitable for industrialized production. According to the pickled Chinese cabbage shreds, the defects that in the prior art, pickled Chinese cabbages are inconvenient to eat, packaged pickled Chinese cabbages are poor in mouthfeel, and the existing pickled Chinese cabbages are low in nutritional value can be effectively overcome, the effects of dispelling wind and clearing away heat, dissipating dampness and relieving summer heat and calming the heart and soothing the nerves are achieved if the pickled Chinese cabbages are eaten for a long term, the treatment effect is significant, and the pickled Chinese cabbage shreds are suitable for people of all ages.

The invention discloses a traditional Chinese medicinal preparation for treating decompensated cirrhosis, and relates to a traditional Chinese medicinal preparation; the traditional Chinese medicinal preparation for treating decompensated cirrhosis is characterized by consisting of the following traditional Chinese medicinal raw materials in parts by weight: 15-50 parts of radix et rhizoma malloti apeltae, 10-50 parts of radix rhodomyrti, 15-50 parts of radix millettiae speciosae, 10-50 parts of root bark or stem bark of aralia chinensis linn., 15-50 parts of root of beautiful phyllodium, 15-50 parts of root of sachalin raspberry, 15-50 parts of radix cudraniae, 15-50 parts of root of rabdosia ternifolia hara, 10-50 parts of herba verbenae, 15-50 parts of roughhaired holly root and 10-20 parts of stem and leaf of Hongkong pavetta; and the traditional Chinese medicinal preparation can be reasonably prepared into such dosage forms as decoction, mixture, syrup, tablets, capsules and the like. The medicine disclosed by the invention has relatively good anti-inflammatory, antiviral and anti-fibrosis functions on liver inflammation; and the medicine can be used for effectively treating the liver inflammation of the decompensated cirrhosis disease and preventing the development from liver inflammation to liver cirrhosis.

The invention discloses milky tea melon seed crisp chips and a preparation method thereof. The milky tea melon seed crisp chips are prepared from the following raw materials in parts by weight: 300-330 parts of melon seeds, 2-3 parts of corn stigma, 2-3 parts of cyclocarya paliurus leaves, 1.5-2 parts of radix polygonati officinalis, 3-4 parts of liquorice, 3-3.5 parts of rose, 1-2 parts of chuanminshen violaceum, 1-1.5 parts of rubus sachalinensis, 4-5 parts of garlic, 5-6 parts of bitter gourd, 100-110 parts of taro, 15-20 parts of milky tea, 4-6 parts of collagen powder, 8-10 parts of pearl powder, 10-12 parts of protein powder and 250-300 parts of rye meal. The milky tea melon seed crisp chips are scientific and reasonable in formula, has a simple processing method, is easy to promote, crisp to taste, is fragrant and sweet, and is a leisure health food, has the nutritional quality of the melon seeds, and can achieve the effects of calming liver, benefiting gallbladder, tonifying spleen, eliminating dampness, enriching yin, nourishing kidney, regulating the middle warmer and nourishing stomach after long-time eating.

The present disclosure relates generally to terpene glycosides, such as certain such compounds extracted from Stevia rebaudiana Bertoni, Rubus suavissimus, or Siraitia grosvenorii. The disclosure also provides for the use of such compounds as food ingredients, flavors, and sweeteners, and related methods. The disclosure also provides ingestible compositions comprising such compounds, as well as processes for extracting such compounds selectively from certain plant sources.

The invention relates to a traditional Chinese medicament for treating systemic lupus erythematosus. The traditional Chinese medicament is prepared from the following medicinal materials in parts by weight: 12 parts of sophora alopecuroides, 14 parts of apiosdelavayi franch, 3 parts of azurite, 10 parts of rubus sachalinensis, 12 parts of phyllagathis caualeriei guil, 14 parts of asiatic elder leaf, 12 parts of common seepweed herb, 5 parts of urtica laetevirens, 10 parts of dendrolobium triangulare, 12 parts of wide-leaf pyrrosia, 10 parts of premnaurticifolia rehd, 14 parts of botrypus virginianus, 12 parts of spiny jujube leaf, 15 parts of justicia procumbens and 10 parts of monostroma nitidum. Clinical experiments prove that the traditional Chinese medicament can be used for safely and effectively treating systemic lupus erythematosus.

The present disclosure relates generally to terpene glycosides, such as certain such compounds extracted from Stevia rebaudiana Bertoni, Rubus suavissimus, or Siraitia grosvenorii. The disclosure also provides for the use of such compounds as food ingredients, flavors, and sweeteners, and related methods. The disclosure also provides ingestible compositions comprising such compounds, as well as processes for extracting such compounds selectively from certain plant sources.

The invention discloses a traditional Chinese medicine for treating periporitis and multiple sweat gland abscesses. The traditional Chinese medicine comprises cucubalus root, prinsepia utilis, Raphidophora decursiva, leaves of Alstonia mairei, pyrolusite, snakeroot, whiteflower leadword root, Indian skullcap herb, rubus alceaefolius poir, root or stem of Yunnan euonymus, Artemisia japonica, common scouring rush herb, remote lemongrass herb, notopterygium root, Chinese wampee leaves, herba schizonepetae, Mentha spicata, periostracum cicada, lens culinaris, capitate knotweed herb, slenderstalk mahonia leaves, paulownia root, plum root and Maesa indica. The traditional Chinese medicine is prepared from pure natural Chinese herbal medicines as raw materials, realizes simultaneous treatment of principal and subordinate symptoms, has definite therapeutic effects and no toxic or side effect and reduces a recurrence rate.

The invention belongs to the technical field of medicine and particularly relates to a medicine composition for treating kidney-qi non-consolidation type primary glomerular hematuria. The medicine composition is composed of, by weight, 4-8 parts of greywhitehair raspberry fruits, 4-8 parts of rhizome gymnadenia, 4-8 parts of argy wormwood fruits, 4-8 parts of strobiles of cunninghamia lanceolata (lamb.) hook., 4-8 parts of rubus sachalinensis roots, 4-8 parts of wooden diaphragms of juglans regia L., 4-8 parts of hill gooseberries, 4-8 parts of fruit of terminalia bellirica (gaertn.) roxb., 4-8 parts of ginseng rhizomes, 4-8 parts of undulateleaf aralia, undulate aralia roots and 4-8 parts of licorice roots. All medicinal raw materials are combined to achieve the effects of tonifying kidney-qi and stopping bleeding through astringent therapy. The medicine composition can effectively improve clinical symptoms and body signs of patients, lower the number of red blood cells in urine, decrease urine protein and raise the glomerular filtration rate.